Altana Pharma/Nycomed Investigational Site

Schwetzingen 68723

0 studies enrolling now · 1 studies all time

What they study most

Chronic Obstructive Pulmonary Disease (COPD)

Studies at this site

• Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124) — Completed